| EAU guidelines on renal cell carcinoma: 2014 update B Ljungberg, K Bensalah, S Canfield, S Dabestani, F Hofmann, M Hora, ... European urology 67 (5), 913-924, 2015 | 2829 | 2015 |
| Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study AR Rastinehad, H Anastos, E Wajswol, JS Winoker, JP Sfakianos, ... Proceedings of the National Academy of Sciences 116 (37), 18590-18596, 2019 | 703 | 2019 |
| Systematic review and meta-analysis of diagnostic accuracy of percutaneous renal tumour biopsy L Marconi, S Dabestani, TB Lam, F Hofmann, F Stewart, J Norrie, A Bex, ... European urology 69 (4), 660-673, 2016 | 570 | 2016 |
| Guidelines on renal cell carcinoma B Ljungberg, K Bensalah, A Bex, S Canfield, S Dabestani, F Hofmann, ... European association of urology 2013, 2013 | 497 | 2013 |
| Systematic review of oncological outcomes following surgical management of localised renal cancer S MacLennan, M Imamura, MC Lapitan, MI Omar, TBL Lam, ... European urology 61 (5), 972-993, 2012 | 450 | 2012 |
| Review of major adverse effects of androgen‐deprivation therapy in men with prostate cancer LG Taylor, SE Canfield, XL Du Cancer 115 (11), 2388-2399, 2009 | 347 | 2009 |
| Local treatments for metastases of renal cell carcinoma: a systematic review S Dabestani, L Marconi, F Hofmann, F Stewart, TBL Lam, SE Canfield, ... The Lancet Oncology 15 (12), e549-e561, 2014 | 337 | 2014 |
| Systematic review of perioperative and quality-of-life outcomes following surgical management of localised renal cancer S MacLennan, M Imamura, MC Lapitan, MI Omar, TBL Lam, ... European urology 62 (6), 1097-1117, 2012 | 328 | 2012 |
| Key steps in conducting systematic reviews for underpinning clinical practice guidelines: methodology of the European Association of Urology T Knoll, MI Omar, S Maclennan, V Hernandez, S Canfield, Y Yuan, ... European urology 73 (2), 290-300, 2018 | 170 | 2018 |
| Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease (clinical stage TxN1-2M0): the impact of aggressive surgical resection on patient outcome SE Canfield, AM Kamat, RF Sánchez-Ortiz, M Detry, DA Swanson, ... The Journal of urology 175 (3), 864-869, 2006 | 160 | 2006 |
| A systematic review and meta-analysis comparing the effectiveness and adverse effects of different systemic treatments for non-clear cell renal cell carcinoma S Fernandez-Pello, F Hofmann, R Tahbaz, L Marconi, TB Lam, L Albiges, ... European urology 71 (3), 426-436, 2017 | 151 | 2017 |
| Updated EAU Guidelines for Clear Cell Renal Cancer Patients Who Fail VEGF Targeted Therapy. T Powles, M Staehler, B Ljungberg, K Bensalah, SE Canfield, ... European urology 69 (1), 4-6, 2015 | 133 | 2015 |
| Systematic review of surgical management of nonmetastatic renal cell carcinoma with vena caval thrombus M Lardas, F Stewart, D Scrimgeour, F Hofmann, L Marconi, S Dabestani, ... European urology 70 (2), 265-280, 2016 | 111 | 2016 |
| The impact of minimally invasive surgeries for the treatment of symptomatic benign prostatic hyperplasia on male sexual function: a systematic review RW Frieben, HC Lin, PP Hinh, F Berardinelli, SE Canfield, R Wang Asian journal of andrology 12 (4), 500, 2010 | 96 | 2010 |
| Rating the quality of evidence and the strength of recommendations using GRADE SE Canfield, P Dahm World journal of urology 29, 311-317, 2011 | 74 | 2011 |
| Imaging in suspected renal-cell carcinoma: systematic review C Vogel, B Ziegelmüller, B Ljungberg, K Bensalah, A Bex, S Canfield, ... Clinical genitourinary cancer 17 (2), e345-e355, 2019 | 73 | 2019 |
| A core outcome set for localised prostate cancer effectiveness trials S MacLennan, PR Williamson, H Bekema, M Campbell, C Ramsay, ... BJU international 120 (5B), E64-E79, 2017 | 65 | 2017 |
| Assessment of the methodological quality of systematic reviews published in the urological literature from 1998 to 2008 SL MacDonald, SE Canfield, SF Fesperman, P Dahm The Journal of Urology 184 (2), 648-653, 2010 | 64 | 2010 |
| Androgen receptor splice variant, AR-V7, as a biomarker of resistance to androgen axis-targeted therapies in advanced prostate cancer T Zhang, LI Karsh, MJ Nissenblatt, SE Canfield Clinical genitourinary cancer 18 (1), 1-10, 2020 | 62 | 2020 |
| A novel bystander effect involving tumor cell-derived Fas and FasL interactions following Ad. HSV-tk and Ad. mIL-12 gene therapies in experimental prostate cancer SJ Hall, SE Canfield, Y Yan, W Hassen, WA Selleck, SH Chen Gene therapy 9 (8), 511-517, 2002 | 58 | 2002 |
